This inventor holds 1 USPTO granted patent. Top assignee: Novimmune Sa. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Elise Penarrieta: Innovator in Biopharmaceuticals
Introduction
Elise Penarrieta is a prominent inventor based in Crans-Montana, Switzerland. She has made significant contributions to the field of biopharmaceuticals, particularly in the development of innovative therapies. Her work focuses on advancing medical treatments through her research and inventions.
Latest Patents
Elise holds a patent for "Bispecific Antibodies Targeting CD47 and PD-L1 and Methods of Use Thereof." This patent represents a crucial advancement in the treatment of various diseases, showcasing her expertise and dedication to improving healthcare outcomes. She has 1 patent to her name, reflecting her innovative spirit and commitment to scientific progress.
Career Highlights
Elise is currently employed at Novimmune SA, a company known for its cutting-edge research in immunotherapy. Her role at Novimmune allows her to collaborate with other talented professionals in the field, further enhancing her contributions to biopharmaceutical innovation.
Collaborations
Elise has worked alongside notable colleagues such as Xavier Chauchet and Krzysztof Masternak. These collaborations have fostered a dynamic environment for research and development, leading to groundbreaking advancements in their respective fields.
Conclusion
Elise Penarrieta is a remarkable inventor whose work in biopharmaceuticals is paving the way for new therapeutic approaches. Her dedication to innovation and collaboration exemplifies the spirit of scientific inquiry and progress.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile